Minrad International Inc. Q4 2007 Earnings Call Transcript [View article]
This week's 10.6% share price increase came after announcing (1) a losing quarter (a production disruption resulted in a drop in sales); (2) hiring of a new CEO; and (3) dribbling out news that Q1 sales will be about 40% higher than all of 2006! BUF fans saw this coming.
And I still say that $6.50 by the end of 2008 is "likely", and $10/ share is "possible" if a big pharma acquisition is in play. Look at the new CEO's background:
"David DiGiacinto has been named as president and chief operating officer, effective April 1, 2008, when he will take over the day-to- day operations of the Orchard Park company (AMEX: BUF). Plans then call for DiGiacinto to become chief executive officer on Jan. 1, 2009, replacing William Burns Jr.
DiGiacinto is joining Minrad from Spencer Trask & Co., a New York City- based private equity firm, where he served as a Senior Managing Director. Spencer Trask invests primarily in early stage companies with technologies in a variety of market segments. DiGiacinto is familiar with Minrad as an early stage investor in 1999 and provided the primary financing to Minrad through 2002. He also spent 18 years at Pfizer Inc." [bizjournals.com]
Minrad International Inc. Q4 2007 Earnings Call Transcript [View article]
losing quarter (a production disruption resulted in a drop in sales);
(2) hiring of a new CEO; and (3) dribbling out news that Q1 sales will
be about 40% higher than all of 2006! BUF fans saw this coming.
And I still say that $6.50 by the end of 2008 is "likely", and $10/
share is "possible" if a big pharma acquisition is in play. Look at
the new CEO's background:
"David DiGiacinto has been named as president and chief operating
officer, effective April 1, 2008, when he will take over the day-to-
day operations of the Orchard Park company (AMEX: BUF). Plans then
call for DiGiacinto to become chief executive officer on Jan. 1, 2009,
replacing William Burns Jr.
DiGiacinto is joining Minrad from Spencer Trask & Co., a New York City-
based private equity firm, where he served as a Senior Managing
Director. Spencer Trask invests primarily in early stage companies
with technologies in a variety of market segments. DiGiacinto is
familiar with Minrad as an early stage investor in 1999 and provided
the primary financing to Minrad through 2002. He also spent 18 years
at Pfizer Inc." [bizjournals.com]
Dave